Home > News > India News > Article > Tamil Nadu reports BA4 sub variant of Omicron claims Health minister Ma Subramanian

Tamil Nadu reports BA.4 sub-variant of Omicron, claims Health minister Ma Subramanian

Updated on: 21 May,2022 03:36 PM IST  |  Chennai
ANI |

India's first confirmed case of the BA.4 sub-variant of Omicron has been reported from Hyderabad, according to Indian SARS-CoV-2 Genomics Consortium (INSACOG) data

Tamil Nadu reports BA.4 sub-variant of Omicron, claims Health minister Ma Subramanian

Representative image


India's first case of BA.4 sub-variant of Omicron from Tamil Nadu on Saturday, claims Tamil Nadu Health Minister Ma Subramanian.

Addressing the reporters today, Tamil Nadu Health Minister Ma Subramanian said, "One case of BA.4, a sub-variant of Omicron, has been recorded in Chengalpattu District near Chennai."




"The family, where the case was reported has two Covid-19 positive cases. The mother and her daughter got tested positive for Covid on May 4. They don't have any travel history. Both are vaccinated with two doses in the nationwide Covid-19 vaccination drive. Their contact has been traced and tested. Both the infected individuals are keeping fine at the moment," the Health Minister said.


India's first confirmed case of the BA.4 sub-variant of Omicron has been reported from Hyderabad, according to Indian SARS-CoV-2 Genomics Consortium (INSACOG) data.

"After detecting the first case of BA.4, the contact tracing has already been started of those who came in contact with a person who travelled to Hyderabad from South Africa. He was asymptomatic and the sample was collected on May 9," sources said to ANI on Friday evening.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.


This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK